Cargando…

Xanthohumol Prevents Atherosclerosis by Reducing Arterial Cholesterol Content via CETP and Apolipoprotein E in CETP-Transgenic Mice

BACKGROUND: Xanthohumol is expected to be a potent anti-atherosclerotic agent due to its inhibition of cholesteryl ester transfer protein (CETP). In this study, we hypothesized that xanthohumol prevents atherosclerosis in vivo and used CETP-transgenic mice (CETP-Tg mice) to evaluate xanthohumol as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirata, Hiroshi, Yimin, Segawa, Shuichi, Ozaki, Moeko, Kobayashi, Naoyuki, Shigyo, Tatsuro, Chiba, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500296/ https://www.ncbi.nlm.nih.gov/pubmed/23166663 http://dx.doi.org/10.1371/journal.pone.0049415

Ejemplares similares

Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
por: Mabuchi, Hiroshi, et al.
Publicado: (2014)

Choline Supplementation Does Not Promote Atherosclerosis in CETP-Expressing Male Apolipoprotein E Knockout Mice
por: Collins, Heidi L., et al.
Publicado: (2022)

Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP
por: Ølnes, Åsa Schawlann, et al.
Publicado: (2023)

Exercise Training Favorably Modulates Gene and Protein Expression That Regulate Arterial Cholesterol Content in CETP Transgenic Mice
por: Pinto, Paula R., et al.
Publicado: (2018)

Cholesteryl Ester Transfer Protein (CETP) expression does not affect glucose homeostasis and insulin secretion: studies in human CETP transgenic mice
por: Raposo, Helena F., et al.
Publicado: (2016)

CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet
por: Zhu, Lin, et al.
Publicado: (2018)

CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population
por: Wang, Jun, et al.
Publicado: (2013)

The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain
por: Oestereich, Felix, et al.
Publicado: (2022)

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
por: Kühnast, Susan, et al.
Publicado: (2013)

Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice
por: Schilperoort, Maaike, et al.
Publicado: (2020)

CETP Inhibition: Past Failures and Future Hopes
por: Kosmas, Constantine E., et al.
Publicado: (2016)

A novel swine model for evaluation of dyslipidemia and atherosclerosis induced by human CETP overexpression
por: Chen, Tao, et al.
Publicado: (2017)

Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice
por: Jongejan, Yvonne K., et al.
Publicado: (2021)

The Association of Common SNPs and Haplotypes in CETP Gene with HDL Cholesterol Levels in Latvian Population
por: Radovica, Ilze, et al.
Publicado: (2013)

A Vaccine Targeted at CETP Alleviates High Fat and High Cholesterol Diet-Induced Atherosclerosis and Non-Alcoholic Steatohepatitis in Rabbit
por: Liaw, Yi-Wei, et al.
Publicado: (2014)

CETP Expression in Bone-Marrow-Derived Cells Reduces the Inflammatory Features of Atherosclerosis in Hypercholesterolemic Mice
por: Rentz, Thiago, et al.
Publicado: (2023)

The Link Between Human and Transgenic Animal Studies Involving Postprandial Hypertriglyceridemia and CETP Gene Polymorphisms
por: Kolovou, Genovefa D, et al.
Publicado: (2009)

CETP inhibitors and cardiovascular disease: Time to think again
por: Miller, Norman E
Publicado: (2014)

Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP
por: Yokoyama, Shinji, et al.
Publicado: (2015)

Genetic variants in CETP increase risk of intracerebral hemorrhage
por: Anderson, Christopher D., et al.
Publicado: (2016)

Association of CETP Gene Polymorphisms and Haplotypes with Cardiovascular Risk
por: Piko, Peter, et al.
Publicado: (2023)

CETP inhibitor evacetrapib enters mouse brain tissue
por: Phénix, Jasmine, et al.
Publicado: (2023)

Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol
por: Tietjen, Ian, et al.
Publicado: (2012)

The lipid substrate preference of CETP controls the biochemical properties of HDL in fat/cholesterol-fed hamsters
por: Morton, Richard E., et al.
Publicado: (2021)

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
por: Millar, John S., et al.
Publicado: (2017)

Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice
por: Hu, Chunxiu, et al.
Publicado: (2011)

CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels
por: Lee, Chan Joo, et al.
Publicado: (2019)

eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency
por: Gomaraschi, Monica, et al.
Publicado: (2014)

CETP inhibition in the REVEAL trial: could we aim higher?
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice
por: Hoving, Lisa R., et al.
Publicado: (2018)

The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study
por: Colombo, Gualtiero I., et al.
Publicado: (2021)

Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice
por: van Eenige, Robin, et al.
Publicado: (2021)

Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr(−/−) mice
por: Bell, Thomas A., et al.
Publicado: (2013)

Identification of CETP as a molecular target for estrogen positive breast cancer cell death by cholesterol depleting agents
por: Esau, Luke, et al.
Publicado: (2016)

Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism
por: Deguchi, Hiroshi, et al.
Publicado: (2016)

CETP Activity: A Link between Lipid Metabolism and Coagulation System
por: Hatakeyama, Kinta
Publicado: (2016)

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017)

A sex-specific evolutionary interaction between ADCY9 and CETP
por: Gamache, Isabel, et al.
Publicado: (2021)

CETP and SGLT2 inhibitor combination therapy improves glycemic control
por: Khomtchouk, Bohdan B., et al.
Publicado: (2023)

A Polynesian-specific missense CETP variant alters the lipid profile
por: Moors, Jaye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g4c0ip4bd3ndqqvs9g3goeam0b